PATENTS – patent for formulations of liraglutide – validity of extension of term of patent – where application for extension must concern a patent which discloses a ‘pharmaceutical substance per se’ under s 70 of the Patents Act 1990 – whether ‘pharmaceutical substance’ includes formulations of active ingredients and excipients – whether excipients required to be for distinct therapeutic use
Related Federal Court patent cases
-
Hanwha Solutions Corporation v REC Solar Pte Ltd [2023] FCA 1017
PATENTS – patent for method for manufacturing a solar cell with a surface-passivating dielectric double layer, and corresponding solar cell – infringement – validity – claim construction PATENTS – infringement – construction of method and product claims – no infringement found PATENTS – validity – lack of inventive step – ss 7(2) and (3) of…
-
TMA Capital Australia Pty Ltd v UbiPark Pty Ltd [2024] FCAFC 85
PATENTS – patent for system, method and computer program for an access control system for controlling access to a restricted area (eg, a carpark) PATENTS – infringement – construction of integers of the claims – whether primary judge erred in finding that features in a claim were absent from the respondent’s technology – whether the…
-
Elanco Australasia Pty Ltd v Abbey Laboratories Pty Ltd [2024] FCA 640
PATENTS – appeal from decisions of a Delegate of the Commissioner of Patents refusing grant of patent following amendment – patent for ectoparasitic treatment method and composition – validity – lack of inventive step – s 7(3) of the Patents Act 1990 (Cth) – appeal dismissed
